Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The study is a single-arm, open-label, multicenter clinical trial.The primary purpose of this
trial is to evaluate the incidence of symptomatic intracranial hemorrhage in patients with
acute ischemic stroke within 48 hours after the use of Eptifibatide injection. Patients with
acute ischemic stroke treated with intravascular thrombolytic therapy, mechanical
thrombolysis, angioplasty and so on were treated with Eptifibatide injection on the first
day, followed by the second day, the third day, the discharge day and the 90 days.
Phase:
Phase 3
Details
Lead Sponsor:
Ministry of Science and Technology of the People´s Republic of China